Article Text

Download PDFPDF
Strategies for reducing treatment in mild persistent asthma
  1. Andrew Medford
  1. Respiratory Specialist Registrar, Derriford Hospital;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Inhaled corticosteroids (ICS) are standard treatment for persistent asthma but it is important to “step down” treatment when possible to minimise adverse effects. The optimal strategy for reducing treatment in mild asthma has not yet been determined.

Five hundred patients with mild asthma (pre-bronchodilator FEV1 >60% predicted) well controlled on 4–6 weeks fluticasone 100 μg twice …

View Full Text

Linked Articles

  • PostScript
    Anna Rich David Baldwin Richard Hubbard